Xianglei Liu

Title: Xianglei Liu: Innovator in GABAA Positive Allosteric Modulators

Introduction

Xianglei Liu is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmacology, particularly in the development of GABAA positive allosteric modulators. His innovative work has the potential to impact therapeutic approaches for various neurological conditions.

Latest Patents

One of Xianglei Liu's notable patents is focused on GABAA positive allosteric modulator compounds, methods of making, and uses thereof. This patent describes polymorphs comprising 2',6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]tri-azin-7-yl]biphenyl-2-carbonitrile (TPA023B) or salts thereof. The patent also discloses a crystalline polymorphic salt or co-crystal of TPA023B with phosphoric acid, as well as with sulfuric acid. Additionally, it outlines methods of making and using these compounds.

Career Highlights

Xianglei Liu is currently associated with Neurocycle Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.

Collaborations

Xianglei Liu collaborates with various professionals in his field, including his coworker Jed Hubbs. These collaborations enhance the research and development process, fostering an environment of shared knowledge and expertise.

Conclusion

In summary, Xianglei Liu is a distinguished inventor whose work in GABAA positive allosteric modulators showcases his innovative spirit and dedication to advancing medical science. His contributions are poised to make a significant impact in the field of pharmacology.